Franklin Resources
IMVT icon

Franklin Resources’s Immunovant IMVT Stock Holding History

Franklin Resources’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-984,063
Closed -$24.4M – 3023
2024
Q4 		$24.4M Sell
984,063
-65,616
-6% -$1.86M 0.01% 839
2024
Q3 		$30.9M Sell
1,049,679
-52,189
-5% -$1.54M 0.01% 747
2024
Q2 		$29.1M Buy
1,101,868
+232,652
+27% +$6.62M 0.01% 735
2024
Q1 		$28.1M Buy
869,216
+330,119
+61% +$12M 0.01% 756
2023
Q4 		$22.7M Buy
+539,097
New +$19.8M 0.01% 724
2023
Q3 		– Sell
-22,379
Closed -$425K – 2729
2023
Q2 		$425K Buy
+22,379
New +$417K ﹤0.01% 2040

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Franklin Resources's IMVT Position: Q1 2025 in Review

Franklin Resources sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 984,063 shares — an estimated $24.4M sold.

Franklin Resources first reported a position in IMVT in Q2 2023 and held it in 6 quarters. The position peaked at $30.9M in Q3 2024. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Franklin Resources reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Franklin Resources sold 984,063 Immunovant shares in Q1 2025, an estimated $24.4M.
  • Franklin Resources first reported a position in Immunovant in Q2 2023 and held it in 6 quarters.
  • Franklin Resources's Immunovant position peaked at $30.9M in Q3 2024.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Franklin Resources's 13F filing for Q1 2025, filed 13 May 2025.